Tenet Healthcare Corporation (THC) — Financial statements
Income statement, balance sheet, and cash flow for Tenet Healthcare Corporation — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 21,310↑3.1% | 20,665↑0.6% | 20,548↑7.2% | 19,174↓1.6% | 19,485 | |
| Cost of Revenue | 3,780↓69.7% | 12,456↓2.3% | 12,743↑5.1% | 12,126↓0.7% | 12,217 | |
| Gross Profit | 17,530↑113.5% | 8,209↑5.2% | 7,805↑10.7% | 7,048↓3.0% | 7,268 | |
| Operating Expenses | ||||||
| R&D Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| General & Administrative Expenses | 8,705↓1.1% | 8,801 | 0.00 | 0.00 | 0.00 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 8,705↓1.1% | 8,801↑2005.5% | 418↑1.5% | 412↑0.0% | 412 | |
| Other Expenses | 5,386↑182.3% | -6,548↓234.3% | 4,877↑13.3% | 4,303↑8.0% | 3,985 | |
| Operating Expenses | 14,091↑525.4% | 2,253↓57.5% | 5,295↑12.3% | 4,715↑7.2% | 4,397 | |
| Total Costs & Expenses | 17,871↑21.5% | 14,709↓18.5% | 18,038↑7.1% | 16,841↑1.4% | 16,614 | |
| Operating Results | ||||||
| Operating Income | 3,439↓42.3% | 5,956↑137.3% | 2,510↑7.6% | 2,333↓18.7% | 2,871 | |
| Depreciation & Amortization | 863↑5.5% | 818↓6.0% | 870↑3.4% | 841↓1.6% | 855 | |
| EBITDA | 4,484↓34.9% | 6,892↑103.4% | 3,388↑10.1% | 3,076↓16.1% | 3,666 | |
| EBIT | 3,621↓40.4% | 6,074↑141.2% | 2,518↑12.7% | 2,235↓20.5% | 2,811 | |
| Interest & Other Income | ||||||
| Net Interest Income | -821↑0.6% | -826↑8.3% | -901↓1.2% | -890↑3.6% | -923 | |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Interest Expense | 821↓0.6% | 826↓8.3% | 901↑1.2% | 890↓3.6% | 923 | |
| Non-Operating Income | -182↓54.2% | -118↓1375.0% | -8↓108.2% | 98↑63.3% | 60 | |
| Other Income / Expenses | -639↑9.7% | -708↑20.7% | -893↑9.6% | -988↓0.5% | -983 | |
| Income Before Tax | 2,800↓46.6% | 5,248↑224.6% | 1,617↑20.2% | 1,345↓28.8% | 1,888 | |
| Income Tax Expense | 433↓63.4% | 1,184↑286.9% | 306↓11.0% | 344↓16.3% | 411 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | 2,367↓41.8% | 4,064↑210.0% | 1,311↑31.0% | 1,001↓32.2% | 1,477 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00↓100.0% | 1↑200.0% | -1 | |
| Net Income | 1,407↓56.0% | 3,200↑423.7% | 611↑48.7% | 411↓55.0% | 914 | |
| Bottom-Line Net Income | 1,407↓56.0% | 3,201↑435.3% | 598↑43.1% | 418↓54.3% | 915 | |
| EPS (Basic) | 15.61↓52.7% | 33.02↑449.4% | 6.01↑56.5% | 3.84↓55.1% | 8.55 | |
| EPS (Diluted) | 15.49↓52.6% | 32.70↑472.7% | 5.71↑50.7% | 3.79↓55.0% | 8.42 | |
| Weighted Average Shares | 90↓7.0% | 97↓4.7% | 102↓4.9% | 107↑0.1% | 107 | |
| Weighted Average Diluted Shares | 91↓7.2% | 98↓6.6% | 105↓5.2% | 111↑1.8% | 109 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.